In our article dt. 10.8.09, we had recommended to book partial profits in the script at Rs. 520/- and enter again if the price falls. Subsequently the stock went up to Rs. 600/-. It is now quoting around Rs.446/- as on 17.9.08. It is likely to consolidate around Rs. 410/- to 450/- range.
--------------------------------------------------------------------------
One can enter again around this price now.
--------------------------------------------------------------------------
It is quoting well below its intrinsic worth of Rs. 720/- to 1200/- and likely to give compounded returns of over 26% p.a. for the next 10 years.
-------------------------------------------------------------------------------------
It has also entered into strategic long term alliances with research based MNC agrochem companies for bringing in new molecules and new formulation technologies for commercialization in India. Rallis has 15% stake in Pharma and agrochem contract research firm Advinus Therapeutics-Bangalore (Formerly R&D division of Rallis) which can create great value for Rallis.Rallis is having surplus assets, value of which is maybe equivalent or more than its market capitalization.
---------------------------------------------------------------------------------------------------
No comments:
Post a Comment